skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors

Kelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial
Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial

Craciunescu, Oana I., Ph.D ; Steffey, Beverly A., M.S ; Kelsey, Chris R., M.D ; Larrier, Nicole A., M.D ; Paarz-Largay, Cathy J., PA.-C., M.S ; Prosnitz, Robert G., M.D ; Chao, Nelson, M.D., M.B.A ; Chute, John, M.D ; Gasparetto, Cristina, M.D ; Horwitz, Mitchell, M.D ; Long, Gwynn, M.D ; Rizzieri, David, M.D ; Sullivan, Keith M., M.D

International journal of radiation oncology, biology, physics, 2011-03, Vol.79 (4), p.1248-1255 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial

Green, Michael M.B., MD ; Horwitz, Mitchell E., MD ; Kang, Yubin, MD ; Chao, Nelson J., MD ; Long, Gwynn D., MD ; Rizzieri, David, M.D ; Gasparetto, Cristina, MD ; Sung, Anthony D., MD ; Sarantopoulos, Stefanie, MD, PhD ; Li, Zhiguo, PhD ; Corbet, Kelly ; Riggan-Stuelke, Emily ; Sullivan, Keith, MD ; Wilson, Beth ; Chhabra, Saurabh, MD ; Costa, Luciano V., MD ; Mims, Alice ; Stuart, Robert, MD

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S31-S32

Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.